Catherine C. Fenselau, professor of chemistry and biochemistry at the University of Maryland, is the 2012 recipient of the Award for a Distinguished Contribution in Mass Spectrometry, granted by the American Society for Mass Spectrometry (ASMS). The award honors her pioneering work to apply mass spectrometry to the rapid identification and characterization of intact microorganisms.
Catherine C. Fenselau, professor of chemistry and biochemistry at the University of Maryland, is the 2012 recipient of the Award for a Distinguished Contribution in Mass Spectrometry, granted by the American Society for Mass Spectrometry (ASMS). The award honors her pioneering work to apply mass spectrometry to the rapid identification and characterization of intact microorganisms.
In 1975, Fenselau and J.P. Anhalt were the first to report that biomolecules from different pathogenic bacteria, introduced intact into a mass spectrometer, could be vaporized and directly ionized; could be structurally identified; and that the compositions and abundance of these chemical biomarkers, as revealed in mass spectra, allowed taxonomic distinctions. Fenselau’s pioneering approach of using intact molecular biomarkers for rapid microorganism characterization by mass spectrometry was in sharp contrast to concurrent research advocating vigorous pyrolysis before MS analysis.
In the following decade, Fenselau and her team were the first to evaluate newer ionization methods (such as laser desorption, plasma desorption, and fast atom bombardment) for the rapid MS analysis of nonvolatile biomarkers from intact bacterial cells. Further, her work in fingerprinting and in applying proteomic techniques for microorganisms laid the foundation for major developments in epidemiology to track and prevent disease from infectious diseases.
Currently, Fenselau is developing proteomic and bioinformatic strategies that allow rapid identification of bacteria, spores, protein toxins and viruses, with particular emphasis on characterization of genetically engineered bacteria, bacteria without sequenced genomes and bacteria in mixtures.
Hear Professor Fenselau’s award plenary talk today at 4:45 pm in Exhibit Hall A, on the exhibit level.
Pittcon 2025: Xiao Su Discusses His Work in Electrochemical Separations
March 13th 2025In this video interview with Xiao Su, he dives deeper into the research that he and his team are conducting with redox-active polymers and the applicability of electrochemical approaches in separation science.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Pittcon 2025: Kate Perrault Uptmor Talks About Multidimensional GC and Mentorship
March 13th 2025In our interview with Kate Perrault Uptmor, we asked her about the resources available for those interested in learning more about multidimensional chromatography, and current trends happening in separation science that are of particular note.
Analyzing Effects of Adverse Cardiovascular Events on Chronic Kidney Disease with HPLC
March 13th 2025Researchers investigated the potential association between plasma apolipoprotein M (APOM) levels and the risk of adverse cardiovascular outcomes in individuals with chronic kidney disease (CKD). Plasma sphingosine-1-phosphate (S1P) levels were measured by high performance liquid chromatography (HPLC).